Author: Pompili Maurizio Baldessarini Ross J. Forte Alberto Erbuto Denise Serafini Gianluca Fiorillo Andrea Amore Mario Girardi Paolo
Publisher: MDPI
E-ISSN: 1422-0067|17|10|1700-1700
ISSN: 1422-0067
Source: International Journal of Molecular Sciences, Vol.17, Iss.10, 2016-10, pp. : 1700-1700
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Modern antipsychotic drugs are employed increasingly in the treatment of mood disorders as well as psychoses, stimulating interest in their possible contributions to altering suicidal risk. Clozapine remains the only treatment with an FDA-recognized indication for reducing suicidal risk (in schizophrenia). We carried out a systematic, computerized search for reports of studies involving antipsychotic drug treatment and suicidal behaviors. A total of 19 reports provide data with preliminary support for potential suicide risk-reducing effects of olanzapine, quetiapine, ziprasidone, aripiprazole, and asenapine in addition to clozapine, and provide some support for antipsychotic drug treatment in general. These preliminary findings encourage further testing of antipsychotics for effects on suicidal behavior, making use of explicit, pre-planned assessments of suicidal behavior.
Related content
By Fornaro Michele Stubbs Brendon De Berardis Domenico Perna Giampaolo Valchera Alessandro Veronese Nicola Solmi Marco Ganança Licínia
International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. :
By Chauhan Heli Killinger Bryan A. Miller Cheryl V. Moszczynska Anna
International Journal of Molecular Sciences, Vol. 15, Iss. 4, 2014-04 ,pp. :
By Wang Yu-Kai He Hai-Lun Wang Guo-Fan Wu Hao Zhou Bai-Cheng Chen Xiu-Lan Zhang Yu-Zhong
Marine Drugs, Vol. 8, Iss. 2, 2010-02 ,pp. :